Cefazolin sodium and Singulair drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cefazolin sodium (cefazolin sodium) and Singulair (montelukast sodium). Common drug interactions include extrasystoles among females.
The phase IV clinical study analyzes what interactions people have when they take Cefazolin sodium and Singulair. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.
What is Cefazolin sodium?
Cefazolin sodium has active ingredients of cefazolin sodium. eHealthMe is studying from 3,649 Cefazolin sodium users. Check the latest studies of Cefazolin sodium.
What is Singulair?
Singulair has active ingredients of montelukast sodium. It is often used in asthma. eHealthMe is studying from 129,752 Singulair users. Check the latest studies of Singulair.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
15 people who take Cefazolin sodium and Singulair together, and have interactions are studied.

What are the common drug interactions of Cefazolin Sodium and Singulair, by gender? *:
female:
- Extrasystoles
- Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
- Epistaxis (bleed from the nose)
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Hyperuricaemia (level of uric acid in the blood that is abnormally high)
- Infection
- Pneumonia
- Pulmonary arteriovenous fistula
- Pulmonary congestion (congestion in the lungs)
- Pyrexia (fever)
male:
n/a
What are the common drug interactions of Cefazolin Sodium and Singulair, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Bronchitis bacterial (inflammation of the mucous membrane in the bronchial tubes due to bacterial infection)
- Cardiac failure high output
- Central venous pressure increased
- Epistaxis (bleed from the nose)
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Hyperuricaemia (level of uric acid in the blood that is abnormally high)
- Infection
- Pneumonia
- Pulmonary arteriovenous fistula
- Pulmonary congestion (congestion in the lungs)
30-39:
n/a
40-49:
- Diabetes mellitus inadequate control
- Hypoglycaemia (deficiency of glucose in the bloodstream)
- Hypoglycaemic unconsciousness (unconsciousness due to low blood sugar)
50-59:
n/a
60+:
- Haemorrhage (bleeding)
What are the existing conditions these people have? *
- Cystic Fibrosis (disease of the secretary glands): 9 people, 60.00%
- Hyperuricaemia (level of uric acid in the blood that is abnormally high): 4 people, 26.67%
- Haemostasis (stopping of bleeding): 2 people, 13.33%
- Sputum Abnormal: 2 people, 13.33%
- Aortic Stenosis (obstruction to the outflow of blood from the left ventricle into the aorta): 2 people, 13.33%
- Atelectasis (partial or complete collapse of the lung): 2 people, 13.33%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 13.33%
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 13.33%
- Bronchitis Bacterial (inflammation of the mucous membrane in the bronchial tubes due to bacterial infection): 2 people, 13.33%
- Cardiac Failure High Output: 2 people, 13.33%
* Approximation only. Some reports may have incomplete information.
Do you take Cefazolin sodium and Singulair?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Cefazolin sodium (3,649 reports)
- Singulair (129,752 reports)
Browse all drug interactions of Cefazolin sodium and Singulair:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cefazolin sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Singulair:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cefazolin sodium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Singulair and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .
- Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .
How the study uses the data?
The study uses data from the FDA. It is based on cefazolin sodium and montelukast sodium (the active ingredients of Cefazolin sodium and Singulair, respectively), and Cefazolin sodium and Singulair (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Haldol cause Productive Cough? - 3 seconds ago
- Could Spironolactone cause Brain Herniation? - 5 seconds ago
- Could Kalydeco cause Hepatic Failure? - 10 seconds ago
- Rheumatoid Arthritis and Anorexia - 16 seconds ago
- Could Eliquis cause Nodule? - 25 seconds ago
- Could Ondansetron cause Neonatal Hypoxia? - 33 seconds ago
- Could Paracetamol cause Hypokinesia? - 44 seconds ago
- Could Pseudoephedrine Hydrochloride cause Wound Infection? - a minute ago
- Methotrexate and Pericarditis for Men aged 20-29 - a minute ago
- Could Risperdal cause Gallstones? - a minute ago